Who Paid My Doc
Rafik Abdelsayed
Dentist, Oral and Maxillofacial Pathology Augusta, GA Doctor of Dentistry
NPI 1902854110 CMS profile 1242733
1430 John Wesley Gilbert Drive, Gc 2246, Augusta, GA 30912
General payments
$75
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Rafik Abdelsayed of Augusta, GA is reported in the CMS Open Payments database as having received $75 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 33rd percentile of Dentist, Oral and Maxillofacial Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $75 | 1 |
Beside peers
- Rafik Abdelsayed
- Dentist, Oral and Maxillofacial Pathology median
- Middle half of Dentist, Oral and Maxillofacial Pathology
- National median
In program year 2025, general payments to Rafik Abdelsayed were reported at $0. Among 128 Dentist, Oral and Maxillofacial Pathology profiles paid that year, the median was $91 and the middle half received between $35 and $330.
Show as a table
| Year | Rafik Abdelsayed | Dentist, Oral and Maxillofacial Pathology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $75 | $106 | $28–$326 | $163 |
| 2020 | $0 | $109 | $33–$500 | $114 |
| 2021 | $0 | $104 | $30–$557 | $132 |
| 2022 | $0 | $104 | $37–$432 | $149 |
| 2023 | $0 | $152 | $41–$372 | $160 |
| 2024 | $0 | $100 | $38–$354 | $164 |
| 2025 | $0 | $91 | $35–$330 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 8 drugsPart D claims
373
Drug cost
$22,012
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Pilocarpine Hcl | Generic | 63 | $5,806 | |
| Cevimeline Hcl | Generic | 33 | $4,435 | |
| Dexamethasone | Generic | 73 | $3,883 | |
| Fluocinonide | Generic | 32 | $2,105 | |
| Clobetasol Propionate | Generic | 40 | $1,925 | |
| Clonazepam | Generic | 60 | $1,413 | |
| Nystatin | Generic | 41 | $1,359 | |
| Clotrimazole | Generic | 31 | $1,087 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 692 Part D prescribers listed as Maxillofacial Surgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 15 billing codesPaid by Medicare
$17,741
Medicare patients
190
Services billed
314
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 67% | |
| Arthritis | 49% | |
| Diabetes | 28% | |
| Ischemic heart disease | 23% | |
| Depression | 19% | |
| Chronic kidney disease | 17% | |
| Osteoporosis | 17% | |
| COPD | 15% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Oral and Maxillofacial Pathology in Georgia
Robert Lazerson
Dentist, Oral and Maxillofacial Pathology · Marietta, GA
Asif Taufiq
Dentist, Oral and Maxillofacial Pathology · Lawrenceville, GA
William Campbell
Dentist, Oral and Maxillofacial Pathology · Columbus, GA
Steven Budnick
Dentist, Oral and Maxillofacial Pathology · Decatur, GA
William Hines
Dentist, Oral and Maxillofacial Pathology · Lagrange, GA
Ximena Zornosa
Dentist, Oral and Maxillofacial Pathology · Decatur, GA
Related records
Dentist, Oral and Maxillofacial Pathology in Georgia
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Oral and Maxillofacial Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Georgia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.